<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30194234</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>22</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1091-6490</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>115</Volume>                    <Issue>39</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>09</Month>                        <Day>25</Day>                    </PubDate>                </JournalIssue>                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>            </Journal>            <ArticleTitle>Radioactive (<sup>90</sup>Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>9690-9695</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1809258115</ELocationID>            <Abstract>                <AbstractText>We report combined therapy using upconversion nanoparticles (UCNP) coupled to two therapeutic agents: beta-emitting radionuclide yttrium-90 (<sup>90</sup>Y) fractionally substituting yttrium in UCNP, and a fragment of the exotoxin A derived from <i>Pseudomonas aeruginosa</i> genetically fused with a targeting designed ankyrin repeat protein (DARPin) specific to HER2 receptors. The resultant hybrid complex UCNP-R-T was tested using human breast adenocarcinoma cells SK-BR-3 overexpressing HER2 receptors and immunodeficient mice, bearing HER2-positive xenograft tumors. The photophysical properties of UCNPs enabled background-free imaging of the UCNP-R-T distribution in cells and animals. Specific binding and uptake of UCNP complexes in SK-BR-3 cells was observed, with separate <sup>90</sup>Y- and PE40-induced cytotoxic effects characterized by IC<sub>50</sub> 140 μg/mL (UCNP-R) and 5.2 μg/mL (UCNP-T), respectively. When both therapeutic agents were combined into UCNP-R-T, the synergetic effect increased markedly, ∼2200-fold, resulting in IC<sub>50</sub> = 0.0024 μg/mL. The combined therapy with UCNP-R-T was demonstrated in vivo.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Guryev</LastName>                    <ForeName>Evgenii L</ForeName>                    <Initials>EL</Initials>                    <AffiliationInfo>                        <Affiliation>The Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Volodina</LastName>                    <ForeName>Natalia O</ForeName>                    <Initials>NO</Initials>                    <AffiliationInfo>                        <Affiliation>The Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shilyagina</LastName>                    <ForeName>Natalia Y</ForeName>                    <Initials>NY</Initials>                    <AffiliationInfo>                        <Affiliation>The Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gudkov</LastName>                    <ForeName>Sergey V</ForeName>                    <Initials>SV</Initials>                    <AffiliationInfo>                        <Affiliation>The Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Experimental Clinical Studies, Moscow Regional Research and Clinical Institute (MONIKI), 129110 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Wave Research Center, Prokhorov General Physics Institute of the Russian Academy of Sciences, 119991 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Balalaeva</LastName>                    <ForeName>Irina V</ForeName>                    <Initials>IV</Initials>                    <AffiliationInfo>                        <Affiliation>The Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center of Biomedical Engineering, Sechenov University, 119991 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Volovetskiy</LastName>                    <ForeName>Arthur B</ForeName>                    <Initials>AB</Initials>                    <AffiliationInfo>                        <Affiliation>The Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lyubeshkin</LastName>                    <ForeName>Alexander V</ForeName>                    <Initials>AV</Initials>                    <AffiliationInfo>                        <Affiliation>Center of Crystallography and Photonics, Russian Academy of Sciences, 119333 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sen'</LastName>                    <ForeName>Alexey V</ForeName>                    <Initials>AV</Initials>                    <AffiliationInfo>                        <Affiliation>Scientific and Technical Center &quot;Amplitude&quot; Ltd., Zelenograd, 124460 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ermilov</LastName>                    <ForeName>Sergey A</ForeName>                    <Initials>SA</Initials>                    <AffiliationInfo>                        <Affiliation>Scientific and Technical Center &quot;Amplitude&quot; Ltd., Zelenograd, 124460 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vodeneev</LastName>                    <ForeName>Vladimir A</ForeName>                    <Initials>VA</Initials>                    <AffiliationInfo>                        <Affiliation>The Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Petrov</LastName>                    <ForeName>Rem V</ForeName>                    <Initials>RV</Initials>                    <AffiliationInfo>                        <Affiliation>M. M. Shemyakin &amp; Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zvyagin</LastName>                    <ForeName>Andrei V</ForeName>                    <Initials>AV</Initials>                    <Identifier Source="ORCID">0000-0001-8799-2257</Identifier>                    <AffiliationInfo>                        <Affiliation>The Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia; andrei.zvyagin@mq.edu.au zhores.alferov@ras.ru.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center of Biomedical Engineering, Sechenov University, 119991 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>M. M. Shemyakin &amp; Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Macquarie University, Sydney, NSW 2109, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Alferov</LastName>                    <ForeName>Zhores I</ForeName>                    <Initials>ZI</Initials>                    <AffiliationInfo>                        <Affiliation>Nanotechnology Research and Education Centre of Russian Academy of Sciences, St. Petersburg Academic University, 194021 St. Petersburg, Russia andrei.zvyagin@mq.edu.au zhores.alferov@ras.ru.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Deyev</LastName>                    <ForeName>Sergey M</ForeName>                    <Initials>SM</Initials>                    <AffiliationInfo>                        <Affiliation>The Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>M. M. Shemyakin &amp; Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>07</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>            <NlmUniqueID>7505876</NlmUniqueID>            <ISSNLinking>0027-8424</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004731">Endotoxins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015021">Yttrium Radioisotopes</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="C508053">ERBB2 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="D018719">Receptor, ErbB-2</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2010 Sep;31(27):7078-85</RefSource>                <PMID Version="1">20619791</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Biochem. 1981 Mar 16;115(1):207-16</RefSource>                <PMID Version="1">7227366</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood Adv. 2017 Nov 14;1(24):2281-2294</RefSource>                <PMID Version="1">29296877</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1979 Jan;5(1):85-91</RefSource>                <PMID Version="1">422420</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2010 Nov;31(33):8724-31</RefSource>                <PMID Version="1">20728213</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Ther. 2013 Jan;12(1):48-57</RefSource>                <PMID Version="1">23136186</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Cancer Res. 1977;25:323-88</RefSource>                <PMID Version="1">326003</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biomed Opt. 2013 Jul;18(7):76004</RefSource>                <PMID Version="1">23843082</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumori. 1976 Nov-Dec;62(6):587-98</RefSource>                <PMID Version="1">1025802</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Biother Radiopharm. 2009 Jun;24(3):303-9</RefSource>                <PMID Version="1">19538052</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2016 Mar 21;6(6):762-72</RefSource>                <PMID Version="1">27162548</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biofizika. 2015 Jan-Feb;60(1):38-43</RefSource>                <PMID Version="1">25868339</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Nanotechnol. 2014 Feb;9(2):148-55</RefSource>                <PMID Version="1">24463361</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2015 Feb 15;5(5):515-29</RefSource>                <PMID Version="1">25767618</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2017 Nov;17(11):659-675</RefSource>                <PMID Version="1">29026204</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mini Rev Med Chem. 2011 Jan;11(1):1-17</RefSource>                <PMID Version="1">21235512</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Mar 28;8(13):22048-22058</RefSource>                <PMID Version="1">28423549</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Sci. 2015 Dec 28;17(1):null</RefSource>                <PMID Version="1">26729091</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2017 Jan 12;7(3):614-623</RefSource>                <PMID Version="1">28255354</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2012;2(9):916-66</RefSource>                <PMID Version="1">23082103</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Phys Condens Matter. 2013 May 15;25(19):194101</RefSource>                <PMID Version="1">23611923</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Control Release. 2016 Jul 10;233:48-56</RefSource>                <PMID Version="1">27178808</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Biol (Mosk). 2017 Nov-Dec;51(6):907-926</RefSource>                <PMID Version="1">29271956</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Nanotechnol. 2014 Feb;9(2):93-4</RefSource>                <PMID Version="1">24463360</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2008 Oct;29(30):4122-8</RefSource>                <PMID Version="1">18675453</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Naturae. 2014 Oct;6(4):48-53</RefSource>                <PMID Version="1">25558394</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochimie. 2015 Nov;118:116-22</RefSource>                <PMID Version="1">26319592</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Prog Nucleic Acid Res Mol Biol. 1988;35:95-125</RefSource>                <PMID Version="1">3065826</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2016 Apr 27;6(7):930-47</RefSource>                <PMID Version="1">27217829</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Q J Nucl Med Mol Imaging. 2015 Dec;59(4):420-38</RefSource>                <PMID Version="1">26222274</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nanoscale. 2015 Feb 7;7(5):1709-17</RefSource>                <PMID Version="1">25510961</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2015 Jan;37:425-35</RefSource>                <PMID Version="1">25453970</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2017 Apr 10;7(7):1875-1889</RefSource>                <PMID Version="1">28638474</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Clin Oncol. 2017 Apr 10;8(2):120-134</RefSource>                <PMID Version="1">28439493</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jan 10;8(2):2141-2152</RefSource>                <PMID Version="1">27924064</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mol Biol. 2008 Oct 24;382(5):1211-27</RefSource>                <PMID Version="1">18706916</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1978 Sep;38(9):2651-60</RefSource>                <PMID Version="1">354778</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioconjug Chem. 2014 Dec 17;25(12):2093-100</RefSource>                <PMID Version="1">25385142</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Clin Pract Oncol. 2007 Feb;4(2):86-100</RefSource>                <PMID Version="1">17259930</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Exp Med Biol. 1977 May 22-24;92:21-37</RefSource>                <PMID Version="1">205099</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2016 Apr 27;6(7):918-29</RefSource>                <PMID Version="1">27217828</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017089" MajorTopicYN="N">Ankyrin Repeat</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016503" MajorTopicYN="N">Drug Delivery Systems</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004731" MajorTopicYN="N">Endotoxins</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D053758" MajorTopicYN="N">Nanoparticles</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D036103" MajorTopicYN="N">Nanotechnology</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011550" MajorTopicYN="N">Pseudomonas aeruginosa</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011877" MajorTopicYN="N">Radionuclide Imaging</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011878" MajorTopicYN="N">Radiotherapy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018719" MajorTopicYN="N">Receptor, ErbB-2</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015021" MajorTopicYN="N">Yttrium Radioisotopes</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="Y">combined therapy</Keyword>            <Keyword MajorTopicYN="Y">nuclear medicine</Keyword>            <Keyword MajorTopicYN="Y">targeted therapy</Keyword>            <Keyword MajorTopicYN="Y">theranostics</Keyword>            <Keyword MajorTopicYN="Y">upconversion nanoparticles</Keyword>        </KeywordList>        <CoiStatement>The authors declare no conflict of interest.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>03</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30194234</ArticleId>            <ArticleId IdType="pii">1809258115</ArticleId>            <ArticleId IdType="doi">10.1073/pnas.1809258115</ArticleId>            <ArticleId IdType="pmc">PMC6166851</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>